|
Volumn 34, Issue 5, 2002, Pages 1565-1566
|
First results from a prospective randomized trial comparing steroid-free induction therapy with tacrolimus and MMF versus tacrolimus and steroids in patients after liver transplantation for HCV
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
STEROID;
TACROLIMUS;
CORTICOSTEROID;
DRUG DERIVATIVE;
MYCOPHENOLIC ACID;
PREDNISOLONE;
ADULT;
AGED;
CAUSE OF DEATH;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
GENOTYPE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEPATITIS C;
HUMAN;
INTERMETHOD COMPARISON;
LIVER FIBROSIS;
LIVER TRANSPLANTATION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
STEROID THERAPY;
TREATMENT OUTCOME;
ARTICLE;
COMPARATIVE STUDY;
DRUG COMBINATION;
FEMALE;
FOLLOW UP;
IMMUNOLOGY;
MALE;
MIDDLE AGED;
MORTALITY;
POSTOPERATIVE COMPLICATION;
TIME;
VIROLOGY;
ADRENAL CORTEX HORMONES;
ADULT;
AGED;
COMPARATIVE STUDY;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
HEPATITIS C;
HUMAN;
LIVER TRANSPLANTATION;
MALE;
MIDDLE AGE;
MYCOPHENOLIC ACID;
POSTOPERATIVE COMPLICATIONS;
PREDNISOLONE;
PROSPECTIVE STUDIES;
TACROLIMUS;
TIME FACTORS;
HUMANS;
MIDDLE AGED;
|
EID: 0035993638
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03024-5 Document Type: Conference Paper |
Times cited : (26)
|
References (2)
|